Variant report

Variant	esv3439536
Chromosome Location	chr2:181844232-181847280
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr2:181844944-181845261	HepG2	liver:	n/a	n/a
2	ARID3A	chr2:181846011-181846206	K562	blood:	n/a	n/a
3	ARID3A	chr2:181847132-181847681	K562	blood:	n/a	n/a
4	BACH1	chr2:181845947-181846256	K562	blood:	n/a	n/a
5	BACH1	chr2:181845802-181846240	H1-hESC	embryonic stem cell:	n/a	n/a
6	BACH1	chr2:181844981-181845533	H1-hESC	embryonic stem cell:	n/a	n/a
7	BCL3	chr2:181844341-181844645	GM12878	blood:	n/a	n/a
8	BCL3	chr2:181844883-181845249	GM12878	blood:	n/a	chr2:181845036-181845049
9	BCLAF1	chr2:181845029-181845594	GM12878	blood:	n/a	chr2:181845374-181845383 chr2:181845370-181845383 chr2:181845371-181845380 chr2:181845036-181845049 chr2:181845366-181845379 chr2:181845369-181845382 chr2:181845373-181845386
10	BCLAF1	chr2:181845784-181846336	GM12878	blood:	n/a	chr2:181845931-181845944 chr2:181845930-181845943 chr2:181845928-181845941 chr2:181845930-181845939
11	BCLAF1	chr2:181845290-181845625	GM12878	blood:	n/a	chr2:181845374-181845383 chr2:181845370-181845383 chr2:181845371-181845380 chr2:181845366-181845379 chr2:181845369-181845382 chr2:181845373-181845386
12	BHLHE40	chr2:181844561-181845571	K562	blood:	n/a	chr2:181845110-181845126 chr2:181845367-181845383
13	BHLHE40	chr2:181844934-181845621	GM12878	blood:	n/a	chr2:181845110-181845126 chr2:181845367-181845383
14	BHLHE40	chr2:181846032-181846650	K562	blood:	n/a	n/a
15	BHLHE40	chr2:181844636-181845607	HepG2	liver:	n/a	chr2:181845110-181845126 chr2:181845367-181845383
16	BRCA1	chr2:181844924-181845152	HepG2	liver:	n/a	n/a
17	BRCA1	chr2:181846012-181846207	Hela-S3	cervix:	n/a	n/a
18	BRCA1	chr2:181845331-181845539	H1-hESC	embryonic stem cell:	n/a	n/a
19	CBX3	chr2:181844245-181845648	K562	blood:	n/a	n/a
20	CCNT2	chr2:181844153-181844351	K562	blood:	n/a	n/a
21	CCNT2	chr2:181844593-181846420	K562	blood:	n/a	n/a
22	CEBPB	chr2:181845348-181845474	H1-hESC	embryonic stem cell:	n/a	n/a
23	CEBPD	chr2:181844767-181845577	HepG2	liver:	n/a	n/a
24	CEBPD	chr2:181844973-181845255	HepG2	liver:	n/a	n/a
25	CHD1	chr2:181845924-181846469	GM12878	blood:	n/a	n/a
26	CHD1	chr2:181845981-181846560	H1-hESC	embryonic stem cell:	n/a	n/a
27	CHD1	chr2:181845462-181845491	H1-hESC	embryonic stem cell:	n/a	n/a
28	CHD1	chr2:181845096-181845117	H1-hESC	embryonic stem cell:	n/a	n/a
29	CHD1	chr2:181844990-181845383	GM12878	blood:	n/a	n/a
30	CHD2	chr2:181845894-181846344	K562	blood:	n/a	n/a
31	CHD2	chr2:181844709-181846453	Hela-S3	cervix:	n/a	n/a
32	CHD2	chr2:181844745-181845630	GM12878	blood:	n/a	n/a
33	CHD2	chr2:181844206-181844396	K562	blood:	n/a	n/a
34	CHD2	chr2:181844640-181845647	K562	blood:	n/a	n/a
35	CHD2	chr2:181844789-181845647	H1-hESC	embryonic stem cell:	n/a	n/a
36	CHD2	chr2:181844851-181845578	HepG2	liver:	n/a	n/a
37	CREB1	chr2:181844774-181845692	A549	lung:	n/a	n/a
38	CTCF	chr2:181845440-181845590	NHDF-neo	bronchial:	n/a	chr2:181845489-181845507 chr2:181845491-181845504
39	CTCF	chr2:181845440-181845590	AoAF	blood vessel:	n/a	chr2:181845489-181845507 chr2:181845491-181845504
40	CTCF	chr2:181845420-181845570	GM12873	blood:	n/a	chr2:181845489-181845507 chr2:181845491-181845504
41	CTCF	chr2:181845316-181845631	MCF-7	breast:	n/a	chr2:181845349-181845362 chr2:181845489-181845507 chr2:181845491-181845504
42	CTCF	chr2:181845413-181845600	SK-N-SH_RA	brain:	n/a	chr2:181845489-181845507 chr2:181845491-181845504
43	CTCF	chr2:181845313-181845626	MCF-7	breast:	n/a	chr2:181845349-181845362 chr2:181845489-181845507 chr2:181845491-181845504
44	CTCF	chr2:181845276-181845660	GM12892	blood:	n/a	chr2:181845349-181845362 chr2:181845489-181845507 chr2:181845491-181845504
45	CTCF	chr2:181845440-181845590	GM12801	blood:	n/a	chr2:181845489-181845507 chr2:181845491-181845504
46	CTCF	chr2:181845383-181845610	Medullo	brain:	n/a	chr2:181845489-181845507 chr2:181845491-181845504
47	CTCF	chr2:181845407-181845604	Hela-S3	cervix:	n/a	chr2:181845489-181845507 chr2:181845491-181845504
48	CTCF	chr2:181845321-181845577	HepG2	liver:	n/a	chr2:181845349-181845362 chr2:181845489-181845507 chr2:181845491-181845504
49	CTCF	chr2:181845440-181845590	GM12874	blood:	n/a	chr2:181845489-181845507 chr2:181845491-181845504
50	CTCF	chr2:181844058-181845743	A549	lung:	n/a	chr2:181845349-181845362 chr2:181845489-181845507 chr2:181845491-181845504 chr2:181845109-181845122

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:181845502-181845552	RPTEC	kidney:	n/a
2	chr2:181844876-181844926	AG04450	lung:	fetal
3	chr2:181845005-181845055	T-47D	breast:	n/a
4	chr2:181845489-181845539	GM19239	blood:	n/a
5	chr2:181845005-181845055	AG09309	skin:	n/a
6	chr2:181845005-181845055	HCT-116	colon:	n/a
7	chr2:181844876-181844926	GM06990	blood:	n/a
8	chr2:181844876-181844926	Hepatocyte	liver:	n/a
9	chr2:181846182-181846232	AG09319	gingival:	n/a
10	chr2:181845489-181845539	HCPEpiC	choroid plexus:	n/a
11	chr2:181846182-181846232	SK-N-SH_RA	brain:	n/a
12	chr2:181845411-181845461	GM12878	blood:	n/a
13	chr2:181846182-181846232	PANC-1	pancreas:	n/a
14	chr2:181845411-181845461	ECC-1	luminal epithelium:	n/a
15	chr2:181846182-181846232	ovcar-3	ovarian:	n/a
16	chr2:181846182-181846232	HNPCEpiC	eye:	n/a
17	chr2:181844876-181844926	HCT-116	colon:	n/a
18	chr2:181846182-181846232	AG09309	skin:	n/a
19	chr2:181845005-181845055	BE2_C	brain:	n/a
20	chr2:181846182-181846232	LNCaP	prostate:	n/a
21	chr2:181845502-181845552	GM12878	blood:	n/a
22	chr2:181845005-181845055	K562	blood:	n/a
23	chr2:181846182-181846232	PFSK-1	brain:	n/a
24	chr2:181845489-181845539	RPTEC	kidney:	n/a
25	chr2:181845502-181845552	HUVEC	blood vessel:	n/a
26	chr2:181845502-181845552	PrEC	prostate:	n/a
27	chr2:181845411-181845461	AG04449	skin:	fetal
28	chr2:181845005-181845055	SAEC	small airway:	n/a
29	chr2:181845005-181845055	HMEC	breast:	n/a
30	chr2:181845489-181845539	HUVEC	blood vessel:	n/a
31	chr2:181845005-181845055	HCM	heart:	n/a
32	chr2:181845005-181845055	HCF	heart:	n/a
33	chr2:181845411-181845461	HCT-116	colon:	n/a
34	chr2:181844876-181844926	MCF10A-Er-Src	breast:	n/a
35	chr2:181846182-181846232	HCF	heart:	n/a
36	chr2:181846182-181846232	U87	brain:	n/a
37	chr2:181845005-181845055	PrEC	prostate:	n/a
38	chr2:181844876-181844926	Caco-2	colon:	n/a
39	chr2:181845005-181845055	Caco-2	colon:	n/a
40	chr2:181844876-181844926	MCF-7	breast:	n/a
41	chr2:181845005-181845055	SK-N-MC	brain:	n/a
42	chr2:181845489-181845539	NHBE	bronchial:	n/a
43	chr2:181845411-181845461	GM12891	blood:	n/a
44	chr2:181846182-181846232	HIPEpiC	eye:	n/a
45	chr2:181846182-181846232	H1-hESC	embryonic stem cell:	embryo
46	chr2:181845411-181845461	HEK293	kidney:	embryo
47	chr2:181846182-181846232	GM19239	blood:	n/a
48	chr2:181845411-181845461	PFSK-1	brain:	n/a
49	chr2:181844876-181844926	Jurkat	blood:	n/a
50	chr2:181845411-181845461	HMEC	breast:	n/a

No.	Distal block	Cell Line	Cell type
1	chr2:181829069..181832020-chr2:181844085..181846532,2	MCF-7	breast:
2	chr2:181845181..181847277-chr7:100464247..100466142,2	MCF-7	breast:
3	chr2:181845093..181847328-chr2:182755996..182757943,2	K562	blood:
4	chr2:181555811..181558550-chr2:181846192..181848337,2	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-CERKL-3	chr2:181844154-181844393	ENSG00000236153.1
2	lnc-CERKL-3	chr2:181844793-181844817	ENSG00000236153.1

Variant related genes	Relation type
ENSG00000236153	TF binding region
UBE2E3	TF binding region
ENSG00000236153	CpG island
UBE2E3	CpG island
ENSG00000087077	chromatin interactions
ENSG00000260742	chromatin interactions
ENSG00000225258	chromatin interactions
ENSG00000170035	chromatin interactions
ENSG00000138434	chromatin interactions

Extended variants
information (count: 84 )
Associated
traits (count: 49 )

Variant overlapped rSNPs/rCNVs (count:84 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs532969051	chr2:181844271-181844272	Active TSS Enhancers Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
2	rs552409186	chr2:181844272-181844273	Active TSS Enhancers Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
3	rs377598838	chr2:181844283-181844284	Active TSS Enhancers Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
4	rs4595925	chr2:181844316-181844317	Active TSS Enhancers Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region Chromatin interactive region lncRNA	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs149914180	chr2:181844342-181844343	Active TSS Enhancers Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
6	rs10203106	chr2:181844375-181844376	Active TSS Enhancers Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region Chromatin interactive region lncRNA	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
7	rs180791827	chr2:181844385-181844386	Active TSS Enhancers Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
8	rs186556697	chr2:181844409-181844410	Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs73977152	chr2:181844414-181844415	Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs386653254	chr2:181844421-181844422	Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs28362473	chr2:181844494-181844495	Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
12	rs371500664	chr2:181844530-181844531	Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs28362474	chr2:181844544-181844545	Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
14	rs144956481	chr2:181844558-181844559	Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs190666836	chr2:181844559-181844560	Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs574365114	chr2:181844609-181844610	Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs539849147	chr2:181844627-181844628	Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs560151820	chr2:181844674-181844675	Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs577028913	chr2:181844680-181844681	Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs545991429	chr2:181844727-181844728	Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs28362475	chr2:181844788-181844789	Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs562648664	chr2:181844793-181844794	Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
23	rs369437711	chr2:181844860-181844861	Active TSS Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
24	rs13024011	chr2:181844876-181844877	Active TSS Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
25	rs548453363	chr2:181844890-181844891	Active TSS Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
26	rs561878303	chr2:181844896-181844897	Active TSS Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
27	rs533122550	chr2:181844942-181844943	Active TSS Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
28	rs546823414	chr2:181845017-181845018	Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
29	rs371924755	chr2:181845021-181845022	Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
30	rs546687931	chr2:181845036-181845037	Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
31	rs566595604	chr2:181845045-181845046	Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
32	rs538772646	chr2:181845063-181845064	Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
33	rs181917271	chr2:181845136-181845137	Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
34	rs569093954	chr2:181845142-181845143	Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
35	rs538096927	chr2:181845182-181845183	Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
36	rs555242261	chr2:181845231-181845232	Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
37	rs187042945	chr2:181845320-181845321	Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
38	rs562787925	chr2:181845369-181845370	Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
39	rs367736780	chr2:181845370-181845371	Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
40	rs28362476	chr2:181845383-181845384	Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
41	rs191441558	chr2:181845428-181845429	Weak transcription Active TSS	TF binding region CpG island Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
42	rs182651818	chr2:181845573-181845574	Weak transcription Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
43	rs553508715	chr2:181845578-181845579	Weak transcription Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
44	rs185375433	chr2:181845584-181845585	Weak transcription Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
45	rs576942719	chr2:181845595-181845596	Weak transcription Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
46	rs545896915	chr2:181845597-181845598	Weak transcription Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
47	rs189894002	chr2:181845658-181845659	Weak transcription Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
48	rs112680589	chr2:181845751-181845752	Weak transcription Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
49	rs182176972	chr2:181845794-181845795	Weak transcription Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
50	rs538240063	chr2:181845928-181845929	Weak transcription Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:49)

Disease	PMID	Source
Breast cancer	17603634	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Ependymoma	16718352	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	18522746	CNVD
Neurodevelopmental disorder	22521361	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Seminomas	18059402	CNVD
Testicular germ cell tumor	18059402	CNVD
Breast cancer	16272173	CNVD
Ewing''s sarcoma	17952124	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
Colorectal cancer	16272173	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Lung cancer	18438408	CNVD
Glioblastoma	21080181	CNVD
Prostate cancer	18632612	CNVD
Sudden cardiac death	19188705	CNVD
Acute myeloid leukemia	20729466	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
small cell lung cancer	20016488	CNVD
Mental retardation	21062444	CNVD
Facial dysmorphism	20548289	CNVD
Mental retardation	20548289	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	21364760	CNVD

Chromatin state (count:477 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:181843000-181844400	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
2	chr2:181843200-181844400	Enhancers	HMEC	breast
3	chr2:181843400-181844600	Enhancers	Brain Substantia Nigra	brain
4	chr2:181843600-181844400	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
5	chr2:181843600-181844400	Enhancers	iPS-15b Cell Line	embryonic stem cell
6	chr2:181843600-181844600	Enhancers	H9 Cell Line	embryonic stem cell
7	chr2:181843600-181844600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
8	chr2:181843600-181844600	Enhancers	Cortex derived primary cultured neurospheres	brain
9	chr2:181843800-181844400	Enhancers	Breast Myoepithelial Primary Cells	Breast
10	chr2:181843800-181844400	Enhancers	NH-A	brain
11	chr2:181843800-181844400	Enhancers	NHDF-Ad	bronchial
12	chr2:181843800-181844600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
13	chr2:181843800-181844600	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
14	chr2:181843800-181844600	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
15	chr2:181843800-181844600	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
16	chr2:181843800-181844600	Enhancers	Brain Cingulate Gyrus	brain
17	chr2:181843800-181844600	Enhancers	Fetal Muscle Leg	muscle
18	chr2:181843800-181848600	Active TSS	Brain Inferior Temporal Lobe	brain
19	chr2:181843800-181849200	Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
20	chr2:181844000-181844400	Enhancers	HUES64 Cell Line	embryonic stem cell
21	chr2:181844000-181844400	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
22	chr2:181844000-181844400	Enhancers	Primary T helper naive cells fromperipheralblood	blood
23	chr2:181844000-181844400	Enhancers	Primary T helper cells PMA-I stimulated	--
24	chr2:181844000-181844400	Enhancers	Muscle Satellite Cultured Cells	--
25	chr2:181844000-181844400	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
26	chr2:181844000-181844400	Enhancers	Brain Angular Gyrus	brain
27	chr2:181844000-181844400	Enhancers	Skeletal Muscle Female	skeletal muscle
28	chr2:181844000-181844600	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
29	chr2:181844000-181844600	Enhancers	Fetal Brain Female	brain
30	chr2:181844000-181844600	Enhancers	Fetal Stomach	stomach
31	chr2:181844000-181844800	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
32	chr2:181844000-181844800	Enhancers	Fetal Heart	heart
33	chr2:181844000-181844800	Flanking Active TSS	K562	blood
34	chr2:181844000-181845200	Active TSS	ES-I3 Cell Line	embryonic stem cell
35	chr2:181844000-181845200	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
36	chr2:181844000-181847400	Active TSS	Stomach Smooth Muscle	stomach
37	chr2:181844200-181844400	Enhancers	iPS-18 Cell Line	embryonic stem cell
38	chr2:181844200-181844400	Bivalent Enhancer	Primary monocytes fromperipheralblood	blood
39	chr2:181844200-181844400	Bivalent/Poised TSS	Primary neutrophils fromperipheralblood	blood
40	chr2:181844200-181844400	Enhancers	Primary B cells from cord blood	blood
41	chr2:181844200-181844400	Enhancers	Primary B cells from peripheral blood	blood
42	chr2:181844200-181844400	Enhancers	Primary T cells from cord blood	blood
43	chr2:181844200-181844400	Enhancers	Primary hematopoietic stem cells short term culture	blood
44	chr2:181844200-181844400	Enhancers	Primary T helper naive cells from peripheral blood	blood
45	chr2:181844200-181844400	Enhancers	Primary T killer memory cells from peripheral blood	blood
46	chr2:181844200-181844400	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
47	chr2:181844200-181844400	Enhancers	Adipose Nuclei	Adipose
48	chr2:181844200-181844400	Enhancers	Liver	Liver
49	chr2:181844200-181844400	Enhancers	Brain Anterior Caudate	brain
50	chr2:181844200-181844400	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links